Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Jun 2026 for Faeth Therapeutics, Inc., €49k.
Filing timeline
BuySaleAnand Kiran Parikh
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +27.9%Entry US$24.67 · Close at T+90 US$31.55
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Anand Kiran Parikh: trading record in brief
Anand Kiran Parikh is a declared insider of Faeth Therapeutics, Inc., with filings sourced from SEC (Form 4). Activity is concentrated on a single trading day, 22 June 2026, with 3 filings.
Every open-market trade on record is a purchase: 1 purchase worth €49k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 option exercises.
The latest filing, published on 24 June 2026, reports an open-market purchase of €49k in Faeth Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Anand Kiran Parikh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
2,806 shares@ US$19.76100.0% of flowCommon StockSEC:0002111813-26-000010:0
Canonical exit: 20 Sept 2026 (T+90)
45,252 sharesCommon StockSEC:0002111813-26-000010:1
8,213 sharesCommon StockSEC:0002111813-26-000010:2
3 of 3 declarations
